Titan Pharmaceuticals, Inc. Noncash Contribution Expense
Titan Pharmaceuticals, Inc. reported Noncash Contribution Expense of $2.20 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashContributionExpense · last filed 2025-08-14
- 2025-06-30: Noncash Contribution Expense 6 month $2.20M.
| Period end | Noncash Contribution Expense 6 month |
|---|---|
| 2025-06-30 | $2.20M 10-Q · filed 2025-08-14 |